Michele Wible

Anidulafungin versus Fluconazole for Invasive Candidiasis

Annette C. Reboli, Coleman Rotstein, Peter G. Pappas et al. · New England Journal of Medicine · 2007 · 888 citations · Full text

A Randomized, Double-Blind Trial of Anidulafungin versus Fluconazole for the Treatment of Esophageal Candidiasis

David S. Krause, A. E. Simjee, C.E.J. Van Rensburg et al. · Clinical Infectious Diseases · 2004 · 243 citations · Full text

Antifungal Agent, Antifungal Agents, Double-blind Trial +10

Phase 2, Randomized, Dose-Ranging Study Evaluating the Safety and Efficacy of Anidulafungin in Invasive Candidiasis and Candidemia

David S. Krause, John F. Reinhardt, José A. Vázquez et al. · Antimicrobial Agents and Chemotherapy · 2004 · 178 citations · Full text

Pharmacokinetics and safety of aztreonam/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study

Oliver A. Cornely, José Miguel Cisneros, Julián Torre‐Cisneros et al. · Journal of Antimicrobial Chemotherapy · 2019 · 115 citations · Full text

Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial

Yehuda Carmeli, José Miguel Cisneros, Mical Paul et al. · The Lancet Infectious Diseases · 2024 · 75 citations

Aztreonam–avibactam Versus Meropenem, Antimicrobial Susceptibility, Antibiotics +13